Literature DB >> 28646328

Parent Perceptions of Medication Treatment for Preschool Children with ADHD.

Katie C Hart1, Rosmary Ros2, Victoria Gonzalez2, Paulo A Graziano2.   

Abstract

This study sought to examine parent perceptions of medication use for 151 preschool children (M age  = 5.05 years, 78% male, 82% Hispanic/Latino) with or at-risk for ADHD who were medication naive. Parents completed questionnaires regarding family background and perceptions of medication treatment. Parents and teachers completed ratings of child diagnostic symptomatology, behavioral functioning, and functional impairment. Results indicate that only 45% of parents were open to the possibility of medication. No associations were found between child demographics, severity of ADHD symptoms, or level of functional impairment and parental openness to medication. On the other hand, children of parents who were open to medication tended to have higher levels of oppositionality and aggression (as reported by parents but not teachers) compared with children of parents who were not open to medication. These findings are discussed in the context of early intervention given their implications for a variety of treatment providers.

Entities:  

Keywords:  ADHD; Medication treatment; Parent perceptions; Preschool

Mesh:

Year:  2018        PMID: 28646328     DOI: 10.1007/s10578-017-0737-9

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  31 in total

1.  Psychotropic drug use in very young children.

Authors:  J T Coyle
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

2.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

3.  A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples.

Authors:  Gregory A Fabiano; William E Pelham; Daniel A Waschbusch; Elizabeth M Gnagy; Benjamin B Lahey; Andrea M Chronis; Adia N Onyango; Heidi Kipp; Andy Lopez-Williams; Lisa Burrows-Maclean
Journal:  J Clin Child Adolesc Psychol       Date:  2006-09

4.  Diagnostic Experiences of Children With Attention-Deficit/Hyperactivity Disorder.

Authors:  Susanna N Visser; Benjamin Zablotsky; Joseph R Holbrook; Melissa L Danielson; Rebecca H Bitsko
Journal:  Natl Health Stat Report       Date:  2015-09-03

5.  Heterogeneity in the pharmacological treatment of children with ADHD: cognitive, behavioral, and social functioning differences.

Authors:  Paulo A Graziano; Gary R Geffken; Ayesha S Lall
Journal:  J Atten Disord       Date:  2010-05-21       Impact factor: 3.256

Review 6.  Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth.

Authors:  Anil Chacko; Jeffrey H Newcorn; Nicole Feirsen; Jodi Z Uderman
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

7.  Preschool ADHD Diagnosis and Stimulant Use Before and After the 2011 AAP Practice Guideline.

Authors:  Alexander G Fiks; Michelle E Ross; Stephanie L Mayne; Lihai Song; Weiwei Liu; Jennifer Steffes; Banita McCarn; Robert W Grundmeier; A Russell Localio; Richard Wasserman
Journal:  Pediatrics       Date:  2016-11-15       Impact factor: 7.124

8.  A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder.

Authors:  Gregory A Fabiano; William E Pelham; Erika K Coles; Elizabeth M Gnagy; Andrea Chronis-Tuscano; Briannon C O'Connor
Journal:  Clin Psychol Rev       Date:  2008-11-11

9.  Further evidence of the reliability and validity of DSM-IV ODD and CD in preschool children.

Authors:  Kate Keenan; Lauren S Wakschlag; Barbara Danis; Carri Hill; Marisha Humphries; Jeanne Duax; Radiah Donald
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-04       Impact factor: 8.829

10.  Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014.

Authors:  Susanna N Visser; Melissa L Danielson; Mark L Wolraich; Michael H Fox; Scott D Grosse; Linda A Valle; Joseph R Holbrook; Angelika H Claussen; Georgina Peacock
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-05-06       Impact factor: 17.586

View more
  5 in total

1.  High-End Specificity of the Attention-Deficit/Hyperactivity Problems Scale of the Child Behavior Checklist for Ages 1.5-5 in a Sample of Young Children with Disruptive Behavior Disorders.

Authors:  Natalie Hong; Jonathan S Comer
Journal:  Child Psychiatry Hum Dev       Date:  2019-04

Review 2.  Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder.

Authors:  Sharon Wigal; Phillip Chappell; Donna Palumbo; Shannon Lubaczewski; Sara Ramaker; Richat Abbas
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-01-20       Impact factor: 2.576

3.  Adherence to Recommended Care Guidelines in the Treatment of Preschool-Age Medicaid-Enrolled Children With a Diagnosis of ADHD.

Authors:  Alex Moran; Nicoleta Serban; Melissa L Danielson; Scott D Grosse; Steven P Cuffe
Journal:  Psychiatr Serv       Date:  2018-10-30       Impact factor: 3.084

4.  Intelligent Recognition of Hospital Image Based on Deep Learning: The Relationship between Adaptive Behavior and Family Function in Children with ADHD.

Authors:  Hongyi Zhao; Jiangyu Chen; Yiqi Lin
Journal:  J Healthc Eng       Date:  2021-06-04       Impact factor: 2.682

5.  Child and Parental Characteristics of Medication Use for Attention-Deficit/Hyperactivity Disorder.

Authors:  Beate Oerbeck; Kari Furu; Pal Zeiner; Heidi Aase; Ted Reichborn-Kjennerud; Are Hugo Pripp; Kristin Romvig Overgaard
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-07-14       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.